Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • drop the Hiseqs - get an X10 instead

    In a new episode of Illumina's arbitrary gaming of the sequencing market fight for scientific progress, it opens the X10s and X5s for the resequencing of all genomes:


    Theoretically, this leaves RNA-seq for the Hiseqs.

  • #2
    Originally posted by luc View Post
    In a new episode of Illumina's arbitrary gaming of the sequencing market fight for scientific progress, it opens the X10s and X5s for the resequencing of all genomes:


    Theoretically, this leaves RNA-seq for the Hiseqs.
    Not quite. Illumina is still (arbitrarily) limiting the HiSeq X to "large" genomes. They're trying to encourage (accommodate) large projects sequencing crop species, livestock, model mammalian species, etc. Smaller genomes need not apply.
    AllSeq - The Sequencing Marketplace
    [email protected]
    www.AllSeq.com

    Comment


    • #3
      The press release says:
      " ... will allow for market expansion and population-scale sequencing of non-human species in a variety of markets, including plants and livestock in agricultural research and model organisms in pharmaceutical research. Previously, it has been cost prohibitive to sequence non-human genomes at high coverage. ..."
      This can be anything as far as I can see. Illumina is not going to check on what is being sequenced anyhow.

      Comment


      • #4
        I can't say what Illumina will and won't check, but based on what info we've been able to gather (customer conversations, analyst questions), Illumina definitely intends this to be for large genomes only. That said, I'm not sure how useful such a large platform would be for small genomes - it would take a LOT of samples to fill out a run. But maybe there are ultra-large small genome projects just waiting for this opportunity.
        AllSeq - The Sequencing Marketplace
        [email protected]
        www.AllSeq.com

        Comment


        • #5
          @AllSeq: Analysis of HiSeq X data happens on the attached computer (or in BaseSpace) so this "large" genome restriction could be enforced "inline"?

          It sounds to me like they are opening HiSeq X up for large plant/animal biotech companies that previously could not use HiSeq X. They probably have tens of thousands of samples that could be multiplexed.

          Comment


          • #6
            @GenoMax: We don't use the instruments ourselves, so I'm not really sure about the workflow and exactly how Illumina monitors what's going on. We've heard of a couple of examples of providers 'bending the rules', but it always seems to be with the permission of Illumina. We've never heard of a full-blown 'breach of contract'. Not sure if that elicits a tap on the shoulder from the local FAS or perhaps a friendly call from Jay Flatley? ;-)

            And, yes, I think they're definitely looking to serve the PAG market. It's pretty clear from their quarterly reports (and from what we see on the Sequencing Marketplace) that there's quite a bit of excess X capacity out there. Illumina would love to fill that up (and entice new markets to purchase X's).
            AllSeq - The Sequencing Marketplace
            [email protected]
            www.AllSeq.com

            Comment

            Latest Articles

            Collapse

            • seqadmin
              Essential Discoveries and Tools in Epitranscriptomics
              by seqadmin


              The field of epigenetics has traditionally concentrated more on DNA and how changes like methylation and phosphorylation of histones impact gene expression and regulation. However, our increased understanding of RNA modifications and their importance in cellular processes has led to a rise in epitranscriptomics research. “Epitranscriptomics brings together the concepts of epigenetics and gene expression,” explained Adrien Leger, PhD, Principal Research Scientist on Modified Bases...
              Yesterday, 07:01 AM
            • seqadmin
              Current Approaches to Protein Sequencing
              by seqadmin


              Proteins are often described as the workhorses of the cell, and identifying their sequences is key to understanding their role in biological processes and disease. Currently, the most common technique used to determine protein sequences is mass spectrometry. While still a valuable tool, mass spectrometry faces several limitations and requires a highly experienced scientist familiar with the equipment to operate it. Additionally, other proteomic methods, like affinity assays, are constrained...
              04-04-2024, 04:25 PM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by seqadmin, 04-11-2024, 12:08 PM
            0 responses
            55 views
            0 likes
            Last Post seqadmin  
            Started by seqadmin, 04-10-2024, 10:19 PM
            0 responses
            51 views
            0 likes
            Last Post seqadmin  
            Started by seqadmin, 04-10-2024, 09:21 AM
            0 responses
            45 views
            0 likes
            Last Post seqadmin  
            Started by seqadmin, 04-04-2024, 09:00 AM
            0 responses
            55 views
            0 likes
            Last Post seqadmin  
            Working...
            X